« Previous
Next »
Journal of Cardiothoracic and Vascular Anesthesia
Volume 22, Issue 5
, Pages
675-680
, October 2008
Monitoring Recombinant Factor VIIa Treatment: Efficacy Depends on High Levels of Fibrinogen in a Model of Severe Dilutional Coagulopathy
To access this article, please choose from the options below
M.T. Ganter and S. Schmuck contributed equally to this work.
Supported by Pentapharm GmbH (Munich, Germany), Sienco Inc (Arvada, CO), and Novo Nordisk (Cophenhagen, Denmark). An educational grant for this study was provided by ZLB Behring (Berne, Switzerland). None of the authors is related to or has financial interests in the manufacturers of products studied.
PII: S1053-0770(08)00023-2
doi: 10.1053/j.jvca.2008.01.017
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Cardiothoracic and Vascular Anesthesia
Volume 22, Issue 5
, Pages
675-680
, October 2008
